BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2025.
World J Gastrointest Endosc. Dec 16, 2025; 17(12): 111782
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.111782
Table 3 Outcomes of through the scope clips and over the scope clips in the management of gastrointestinal tract defects
Ref.
Study design
Population characteristics
Outcomes in the clip cohort
Outcomes in control cohort
Additional information
Kirschniak et al[29], 2011Retrospectiven = 50, GI Bleed: n = 27. Perforation: n = 11. Fistulae: n = 8. Pre-op marking: n = 4Primary success: 100%. Recurrence of GI bleed: 2 (7.4%). Recurrence of fistulae: 5 (62.5%). No recurrence of perforationNAHigh recurrence of fistulae despite initial success
Hagel et al[34], 2012Prospectiven = 17 (Iatrogenic perforations: n = 6. AL: n = 3. Complication of PEG: n = 5. Duodenal ulcer perforation: n = 3). Median age: 71 ± 7 yearsSuccessful closure: 11 (64.7%)NASix unsuccessful cases had larger perforation defects and had necrotic or soft inflammatory margins
Voermans et al[33], 2012Prospective, multicentern = 36. Acute iatrogenic perforations. Location: Esophageal: n = 5. Gastric: n = 6. Duodenal: n = 12. Colonic: n = 13. M: 15; F: 21Successful closure: 33 (92%). Clinical success: 32 (89%). Surgery: n = 4. Death: n = 1NADeath occurred in one patient with colonic perforation (even after surgery)
Lee et al[13], 2013Retrospective35 patients with AL after surgery for gastric cancer. M: n = 27, F: n = 8. Median age: 64 Yn = 20. Technical clinical success: 19 (95%). Surgery due to failed endoscopic t/t: n = 1. Death: n = 0n = 15. Death: n = 5. Cause of death: Sepsis, bleeding, HAPEndoscopic modality: Hemoclips: n = 17. Detachable snare: n = 2. Additional fibrin glue: n = 14
Haito-Chavez et al[35], 2014Multicenter, retrospectiven = 188. Fistulae: n = 108. Perforations: n = 48. AL: n = 32Overall success: 60.2%. Success rate for perforations: 90%. Success rate for AL: 73.3%. Success rate for fistulae: 42.9%NASuccess rate is significantly higher for acute defects (like perforations/AL) than for chronic defects (fistulae). Success rate is significantly higher if OTSC is applied for primary therapy (69.1%) than for rescue therapy (46.9%; P = 0.004)
Law et al[37], 2015Retrospectiven = 47. Mean age: 57 ± 14. M: 24; F: 23. Fistula location: Esophagus: n = 3. Stomach: n = 16. Small bowel: n = 18. Colo-rectum: n = 10Initial technical success: 42 (89%). Fistula recurrence: 25 (53%) at median f/u of 178 daysNAPoor long-term outcomes of OTSC: Fistula recurrence around 50% despite OTSC retention
Verlaan et al[14], 2015SRMA24 studies; 21 retrospective, 3 prospective, no RCT. n = 466
Hemoclips: n = 398. OTSC: n = 66. Stents: n = 2
Successful outcome: 419 (89.9%). Success rate of hemoclips: 359 (90.2%). Success rate of OTSC: 58 (87.8%). Success rate of stents: 2 (100%)NALimited by the low methodological quality of included studies
Kobara et al[39], 2019SRMA30 studies. n = 1517Clinical success rate: For perforation: 85% (n = 351). For AL: 66% (n = 97). For fistulae: 52% (n = 388)NAOverall complications: 1.7% (n = 23). Severe complications: 0.59% (n = 9)


Write to the Help Desk